FDANews
FDAnews Device Daily Bulletin

FDA Approves Tandem’s Insulin Pump

Aug. 30, 2017

Tandem Diabetes Care received FDA approval and announced the commercial launch of the t:slim X2 Insulin Pump with Dexcom G5 Mobile continuous glucose monitoring integration.

The device is the first sensor-augmented insulin pump approved to let users make treatment decisions without pricking their finger.

The software featured on this pump will also be available to current t:slim X2 Pump users at no cost using the remote software update. This is Tandem’s fifth new insulin pump launch in five years and the second featuring Dexcom technology.

View today's stories